{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:15:37Z","timestamp":1790493337038,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,27]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Soluble Fas (sFas) is produced as translation products of alternative mRNA splicing, and antagonizes the membranous Fas molecule in Fas\/Fas ligand interactions. We investigated the serum sFas levels in 64 Japanese silicosis patients with no clinical symptoms of autoimmune diseases or malignant tumours, using ELISA for sFas. The serum sFas levels in the silicosis patients were significantly higher than those in healthy volunteers. Elevated serum sFas levels were also detected in patients with systemic lupus erythematosus but, unexpectedly, no difference was observed in sFas levels between progressive systemic sclerosis patients and healthy volunteers. On the other hand, there was no significant difference in the expression of Fas on peripheral blood lymphocytes between the patients with silicosis and age-matched healthy volunteers. These observations provided the first evidence that serum sFas levels are elevated in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. It remains to be clarified whether patients with elevated sFas levels have a tendency to develop autoimmune diseases later, or whether some other distinct factor(s) is necessary to initiate the progression of autoimmune diseases.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1997.tb08332.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:26:24Z","timestamp":1281623184000},"page":"303-309","source":"Crossref","is-referenced-by-count":55,"title":["Elevated soluble Fas\/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours"],"prefix":"10.1093","volume":"110","author":[{"given":"A","family":"TOMOKUNI","sequence":"first","affiliation":[{"name":"Department of Hygiene, Primary Health Care & Preventive Medicine Okayama Rosai-Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"AIKOH","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Primary Health Care & Preventive Medicine Okayama Rosai-Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"MATSUKI","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Primary Health Care & Preventive Medicine Okayama Rosai-Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"ISOZAKI","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Primary Health Care & Preventive Medicine Okayama Rosai-Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"OTSUKI","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Primary Health Care & Preventive Medicine Okayama Rosai-Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"KITA","sequence":"additional","affiliation":[{"name":"Primary Health Care & Preventive Medicin Kusaka Hospital, Bizen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"UEKI","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kawasaki Medical School, Kurashiki"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"KUSAKA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kusaka Hospital, Bizen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"KISHIMOTO","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Okayama Rosai-Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"UEKI","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Primary Health Care & Preventive Medicine Okayama Rosai-Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,7,27]]},"reference":[{"key":"2022011518430336300_b1","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","article-title":"Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science"},{"key":"2022011518430336300_b2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2249.1997.d01-901.x","article-title":"Serum levels of soluble Fas\/ APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases","volume":"107","author":"Jodo","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2022011518430336300_b3","first-page":"3870","article-title":"Elevated soluble Fas (sFas) levels in nonhaematopoietic human malignancy","volume":"56","author":"Midis","year":"1996","journal-title":"Cancer Res"},{"key":"2022011518430336300_b4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"2022011518430336300_b5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","article-title":"Generalized lymphopro-liferative disease in mice, caused by a point mutation in the Fas ligand","volume":"76","author":"Takahashi","year":"1994","journal-title":"Cell"},{"key":"2022011518430336300_b6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/376181a0","article-title":"CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells","volume":"376","author":"Rathmell","year":"1995","journal-title":"Nature"},{"key":"2022011518430336300_b7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0190-9622(90)70062-M","article-title":"Silica-induced scleroderma","volume":"22","author":"Haustein","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"2022011518430336300_b8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.52.7.534","article-title":"Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica","volume":"52","author":"Sanchez-Roman","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"2022011518430336300_b9","first-page":"332","article-title":"Polyclonal human T-cell activation by silicate in vitro","volume":"82","author":"Ueki","year":"1994","journal-title":"Immunology"},{"key":"2022011518430336300_b10","first-page":"395","article-title":"Leukocyte immunophenotypes in bronchoalveolar lavage fluid and peripheral blood of paracoccidioidomycosis, sarcoidosis and silicosis","volume":"6","author":"Tapia","year":"1991","journal-title":"Histol Histopathol"},{"key":"2022011518430336300_b11","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.4049\/jimmunol.149.11.3753","article-title":"Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood","volume":"11","author":"Miyawaki","year":"1992","journal-title":"J Immunol"},{"key":"2022011518430336300_b12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/art.1780381205","article-title":"Levels of soluble Fas\/APO-1\/ CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis","volume":"38","author":"Knipping","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2022011518430336300_b13","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.1780381206","article-title":"Lack of correlation between serum soluble Fas\/APO-1 levels and autoimmune disease","volume":"38","author":"Goel","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2022011518430336300_b14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1172\/JCI118892","article-title":"Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease","volume":"98","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"2022011518430336300_b15","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/clinchem\/42.12.1911","article-title":"Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly","volume":"42","author":"Seishima","year":"1996","journal-title":"Clin Chem"},{"key":"2022011518430336300_b16","first-page":"387","article-title":"Diffuse scleroderma: its frequency; its occurence in stonemasons; its treatment by fibrinolysin-elevations of temperature due to fibrinolysin injections","volume":"12","author":"Bramwell","year":"1914","journal-title":"Ed Med J"},{"key":"2022011518430336300_b17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/thx.8.1.29","article-title":"Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis","volume":"8","author":"Caplan","year":"1953","journal-title":"Thorax"},{"key":"2022011518430336300_b18","first-page":"209","article-title":"Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations","volume":"3","author":"Erasmus","year":"1958","journal-title":"S Afr J Lab Clin Med"},{"key":"2022011518430336300_b19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-66-2-323","article-title":"The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis","volume":"66","author":"Rodnan","year":"1967","journal-title":"Ann Intem Med"},{"key":"2022011518430336300_b20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10408448209003370","article-title":"Immunotoxicology of silica","volume":"10","author":"Uber","year":"1982","journal-title":"Crit Rev Toxicol"},{"key":"2022011518430336300_b21","first-page":"54","volume-title":"Occupational lung disorders","author":"Parkes","year":"1982","edition":"2nd"},{"key":"2022011518430336300_b22","first-page":"50","volume-title":"Occupational lung disorders","author":"Haslam","year":"1994","edition":"3rd"},{"key":"2022011518430336300_b23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2133.1990.tb04189.x","article-title":"Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis","volume":"123","author":"Rustin","year":"1990","journal-title":"Br J Dermatol"},{"key":"2022011518430336300_b24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3835(92)90221-G","article-title":"Activation of human CD4+CD45RA+ T cells by chrysotile asbestos in vitro","volume":"66","author":"Kinugawa","year":"1992","journal-title":"Cancer Lett"},{"key":"2022011518430336300_b25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/349245a0","article-title":"Programmed cell death and extrathymic reduction of V\/38+ CD4+ T cells in mice tolerant to staphylococcus aureus enterotoxin B","volume":"349","author":"Kawabe","year":"1991","journal-title":"Nature"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1997.tb08332.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1997.tb08332.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/110\/2\/303\/42205637\/j.1365-2249.1997.tb08332.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/110\/2\/303\/42205637\/j.1365-2249.1997.tb08332.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:10:02Z","timestamp":1740381002000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/110\/2\/303\/6483346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,7,27]]},"published-print":{"date-parts":[[2007,7,27]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1997.tb08332.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,11]]},"published":{"date-parts":[[1997,11]]}}}